Pyridoxamine, Advanced Glycation Inhibition, and Diabetic Nephropathy

被引：26
作者：
Chen, Joline L. T. [1 ]
Francis, Jean [1 ]
机构：
[1] Boston Univ, Sch Med, Renal Sect, Evans Biomed Res Ctr, Boston, MA 02118 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2012年 / 23卷 / 01期
关键词：
END-PRODUCTS; EXPRESSION; PODOCYTE;
D O I：
10.1681/ASN.2011111097
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6 / 8
页数：3
相关论文
共 23 条
[21]   Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy [J].
Williams, Mark E. ;
Bolton, W. Kline ;
Khalifah, Raja G. ;
Degenhardt, Thorsten P. ;
Schotzinger, Robert J. ;
McGill, Janet B. .
AMERICAN JOURNAL OF NEPHROLOGY, 2007, 27 (06) :605-614
[22]   ADVANCED GLYCATION END-PRODUCTS UP-REGULATE GENE-EXPRESSION FOUND IN DIABETIC GLOMERULAR-DISEASE [J].
YANG, CW ;
VLASSARA, H ;
PETEN, EP ;
HE, CJ ;
STRIKER, GE ;
STRIKER, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) :9436-9440
[23]   Reduced Expression of Lipoic Acid Synthase Accelerates Diabetic Nephropathy [J].
Yi, Xianwen ;
Xu, Longquan ;
Hiller, Sylvia ;
Kim, Hyung-Suk ;
Nickeleit, Volker ;
James, Leighton R. ;
Maeda, Nobuyo .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (01) :103-111
123